|
Real-time Estimate
Cboe BZX
15:23:32 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 2.175 USD | +7.14% |
|
+4.35% | +57.66% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-12 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
ALLO 2.155 $
+6.16%
10.37M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ALLO | 2.155USD | +6.16% | 10.37M $ | |
CBOE
| ALLO | 2.180USD | +7.65% | 296K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 2.12 | 2.22 | 2.78 |
| Spread/Res. | +1.89% | -2.70% | -22.30% |
| Spread/Supp. | +16.13% | +30.12% | +91.15% |
| Support | 1.86 | 1.66 | 1.13 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALLO Stock
- Charts Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
